Virtual Library

Start Your Search

  • WCLC 2017

    18th World Conference on Lung Cancer

    Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan

    Presentation Date(s):  
    • Oct 15 - 18, 2017
    • Total Presentations: 2295

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Download PDF of the Conference Program: Click Here.
    Onsite Conference Program Addendum (17/10/2017): Click Here.
    Download PDF of the Abstract Book: Click Here.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.03 - Chemotherapy/Targeted Therapy

    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 53
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.03-013 - Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

      09:30 - 09:30  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    P1.08 - Locally Advanced NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Locally Advanced NSCLC
    • Presentations: 10
    • Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P1.08-009 - Neutrophilia as Prognostic Biomarker in Locally Advanced Stage III Lung Cancer

      09:30 - 09:30  |  Author(s): A. Schernberg

      • Abstract

      Loading...

  • +

    MA 02 - Emerging Targets

    • Type: Mini Oral
    • Track: Clinical Design, Statistics and Clinical Trials
    • Presentations: 12
    • Moderators:Ravi Salgia
    • Coordinates: 10/16/2017, 11:00 - 12:30, Room 511 + 512
    • +

      MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC

      11:05 - 11:10  |  Author(s): B.P. Levy

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS 01 - Clinical Development of Novel Agents

    • Type: Mini Symposium
    • Track: Clinical Design, Statistics and Clinical Trials
    • Presentations: 5
    • Moderators:S. Mandrekar
    • Coordinates: 10/16/2017, 11:00 - 12:30, Main Hall
    • +

      MS 01.01 - Expansion Cohorts in Phase I Trials: Non Controlled Phase II or Translational Science?

      11:00 - 11:20  |  Presenter: Benjamin Besse

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA 03 - Mediastinal and Esophageal Tumor: Insight and New Treatment

    • Type: Oral
    • Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 8
    • Moderators:M. Chida
    • Coordinates: 10/16/2017, 11:00 - 12:30, Room 311 + 312
  • +

    MA 05 - Immuno-Oncology: Novel Biomarker Candidates

    • Type: Mini Oral
    • Track: Immunology and Immunotherapy
    • Presentations: 15
    • Moderators:Yoichi Nakanishi
    • Coordinates: 10/16/2017, 15:45 - 17:30, Room 303 + 304
    • +

      MA 05.03 - The Early Monitoring of Derived Neutrophil-To Lymphocyte Ratio (dNLR) Could Be a Surrogate Marker of Benefit of Immunotherapy in NSCLC 

      15:55 - 16:00  |  Presenter: Laura Mezquita

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA 05 - Next Generation TKI

    • Type: Oral
    • Track: Advanced NSCLC
    • Presentations: 9
  • +

    P2.01 - Advanced NSCLC

    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 83
    • Coordinates: 10/17/2017, 09:00 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.01-038 - Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient

      09:00 - 09:00  |  Presenter: Marie-Eve Boucher

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.07 - Immunology and Immunotherapy

    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • Presentations: 65
    • Coordinates: 10/17/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
    • +

      P2.07-005 - Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

      09:30 - 09:30  |  Author(s): C. Henon

      • Abstract

      Loading...

    • +

      P2.07-060 - Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients

      09:30 - 09:30  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    MA 10 - Immunotherapy I

    • Type: Mini Oral
    • Track: Immunology and Immunotherapy
    • Presentations: 12
    • Moderators:S. Wang
    • Coordinates: 10/17/2017, 11:00 - 12:30, Room 303 + 304
    • +

      MA 10.11 - Hyperprogressive Disease (HPD) Is Frequent in Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Treated with Anti PD1/PD-L1 Agents (IO)

      12:10 - 12:15  |  Presenter: Roberto Ferrara

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.